Valeant Pharmaceuticals on Tuesday reported a first-quarter loss of $373.7 million, after reporting a profit in the same period a year earlier.
Valeant Pharmaceuticals on Tuesday reported a first-quarter loss of $373.7 million, after reporting a profit in the same period a year earlier.